Northwire Canada EditionMonday, July 13, 2026
Northwire
BMM 3.80 +0.0% CGD 0.510 −10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.790 −13.2% SMY 0.290 +23.4% SAG 1.02 +0.0% NTH 0.165 +0.0% BMM 3.80 +0.0% CGD 0.510 −10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.790 −13.2% SMY 0.290 +23.4% SAG 1.02 +0.0% NTH 0.165 +0.0%
Regulatory

Trulieve Announces Conditional Approval for Texas License

TRUL · Price

Executive Summary

  • Trulieve Cannabis Corp. received conditional approval from the Texas Department of Public Safety for a Dispensing Organization license under the Texas Compassionate Use Program.
  • The license, once fully approved, will allow Trulieve to cultivate, manufacture, and distribute medical cannabis products to patients in Texas.
  • CEO Kim Rivers highlighted the significance of the approval and the company’s intent to expand patient access pending final regulatory clearance.

Key Details

  • Conditional approval granted by the Texas Department of Public Safety for a Dispensing Organization license.
  • License is subject to final approval by the same department.
  • Trulieve TX, Inc. will be authorized to cultivate, manufacture, and distribute high‑quality medical cannabis products in Texas.
  • CEO Kim Rivers statement: “We are excited to be selected for a coveted Texas Dispensing Organization license… Pending necessary approvals, we plan to provide patients compassionate care and expanded access to high quality medical cannabis products.”
  • The approval represents a strategic expansion of Trulieve’s multi‑state operations into the Texas market.

Notable Quotes

“We are excited to be selected for a coveted Texas Dispensing Organization license and we look forward to working with regulators as we complete the licensing process,” – Kim Rivers, CEO, Trulieve
“Pending necessary approvals, we plan to provide patients compassionate care and expanded access to high quality medical cannabis products.” – Kim Rivers, CEO, Trulieve

Read the original news release →

More from Trulieve Cannabis Corp.